OpGen (OPGN) and Editas Medicine (NASDAQ:EDIT) Head-To-Head Comparison – Week Herald
|
OpGen (OPGN) and Editas Medicine (NASDAQ:EDIT) Head-To-Head Comparison
Week Herald It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … |
